Publisher
Springer Science and Business Media LLC
Reference59 articles.
1. Cotogni P, Mussa B, Degiorgis C, De Francesco A, Pittiruti M (2021) Comparative complication rates of 854 central venous access devices for home parenteral nutrition in cancer patients: a prospective study of over 169,000 catheter- days. JPEN J Parenter Enteral Nutr 45(4):768–776. https://doi.org/10.1002/jpen.1939
2. Yue J, Zhang Y, Xu F, Mi A, Zhou Q, Chen B et al (2022) A clinical study of peripherally inserted central catheter-related venous thromboembolism in patients with hematological malignancies. Sci Rep 12(1):9871. https://doi.org/10.1038/s41598-022-13916-5
3. Moss JG, Wu O, Bodenham AR, Agarwal R, Menne TF, Jones BL et al (2021) Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a atheters controlled trial. Lancet. 398(10298):403–415. https://doi.org/10.1016/S0140-6736(21)00766-2
4. Taxbro K, Chopra V (2021) Appropriate vascular access for patients with cancer. Lancet. 398(10298):367–368. https://doi.org/10.1016/S0140-6736(21)00920-X
5. Ho C, Spry C. Central venous access devices (CVADs) and peripherally inserted central catheters (PICCs) for adult and pediatric patients: a review of clinical effectiveness and safety [Internet]. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2017 [acesso em 14 set. 2023]. Disponível em: https://www.ncbi.nlm.nih.gov/books/NBK470804.